Anika Therapeutics, Inc. (ANIK)
15.12
+0.17
(+1.14%)
USD |
NASDAQ |
May 06, 16:00
15.50
+0.38
(+2.51%)
Pre-Market: 08:27
Anika Therapeutics Cash from Investing (Quarterly) : -1.239M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| TELA Bio, Inc. | 0.192M |
| BioCryst Pharmaceuticals, Inc. | -- |
| Masimo Corp. | -4.20M |
| Lantheus Holdings, Inc. | -11.51M |
| Evolus, Inc. | -1.691M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.846M |
| Cash from Financing (Quarterly) | -10.35M |
| Free Cash Flow | 1.039M |
| Free Cash Flow Per Share (Quarterly) | -0.4639 |
| Free Cash Flow to Equity (Quarterly) | -5.765M |
| Free Cash Flow to Firm (Quarterly) | -6.277M |
| Free Cash Flow Yield | 0.48% |